Geneva, Switzerland · Founded 2018 · Privately Held (backing)
Developer of the next-generation radiation therapy technology designed to treat cardiac arrhythmias from outside the heart. EBAMed is based in Geneva, Switzerland and was founded in 2018. Its last reported valuation was $106 million in Jun 2025. It has raised $51.1 million.
Last reported valuation
$105.6M
Oct 2026
Priced at
—
Total raised
$51.1M
Last round
—
Team — not yet on record
No current team members for EBAMed are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EBAMed with a free account
·The complete investor list: 13 names
·Watch EBAMed: the Monday email on marks, rounds and moves
